Cargando…
C-Peptide and Atherogenesis: C-Peptide as a Mediator of Lesion Development in Patients with Type 2 Diabetes Mellitus?
Patients with insulin resistance and early type 2 diabetes exhibit an increased propensity to develop a diffuse and extensive pattern of arteriosclerosis. Typically, these patients show increased levels of C-peptide and over the last years various groups examined the effect of C-peptide in vascular...
Autores principales: | Marx, Nikolaus, Walcher, Daniel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2288642/ https://www.ncbi.nlm.nih.gov/pubmed/18401446 http://dx.doi.org/10.1155/2008/385108 |
Ejemplares similares
-
C-peptide promotes lesion development in a mouse model of arteriosclerosis
por: Vasic, Dusica, et al.
Publicado: (2012) -
C-Peptide: A New Mediator of Atherosclerosis in Diabetes
por: Vasic, Dusica, et al.
Publicado: (2012) -
Proinflammatory Effects of C-Peptide in Different Tissues
por: Vasic, Dusica, et al.
Publicado: (2012) -
C-Peptide as a Therapy for Type 1 Diabetes Mellitus
por: Washburn, Rachel L., et al.
Publicado: (2021) -
C-Peptide-Positive, Autoantibody-Negative Type 1 Diabetes Mellitus
por: Fenner, Rachel M, et al.
Publicado: (2022)